EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SanBio Co's enterprise value is 円30,113.37 Mil.
SanBio Co's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was 円0.00 Mil. Therefore, SanBio Co's EV-to-Revenue for today is .
The historical rank and industry rank for SanBio Co's EV-to-Revenue or its related term are showing as below:
During the past 11 years, the highest EV-to-Revenue of SanBio Co was 5422.84. The lowest was 20.65. And the median was 298.01.
TSE:4592's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.075 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-06-04), SanBio Co's stock price is 円494.00.
SanBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was 円0.00. Therefore, SanBio Co's PS Ratio for today is .
SanBio Co EV-to-Revenue Historical Data
The historical data trend for SanBio Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SanBio Co's EV-to-Revenue
For the Biotechnology subindustry, SanBio Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SanBio Co's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SanBio Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where SanBio Co's EV-to-Revenue falls into.
SanBio Co's current Enterprise Value is 円30,113.37 Mil.
SanBio Co's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SanBio Co's share price for today is 円494.00.
SanBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SanBio Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of SanBio Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4592 has been successfully added to your 